References

Hashimoto's thyroiditis: Epidemiology, pathogenesis, clinic and therapy

10.1016/j.beem.2019.101367 · 2019 · External reference

Global prevalence and epidemiological trends of Hashimoto’s thyroiditis in adults: A systematic review and meta-analysis

10.3389/fpubh.2022.1020709 · 2022 · External reference

Cancer statistics, 2024

10.3322/caac.21820 · 2024 · External reference

2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer

10.1177/10507256251363120 · 2025 · External reference

Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland

10.1001/archsurg.1955.01270080137023 · 1955 · External reference

Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis

10.1371/journal.pone.0269995 · 2022 · External reference

Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside

10.1007/s11154-023-09846-w · 2024 · External reference

Association between Hashimoto's thyroiditis and thyroid cancer in 64,628 patients

10.3389/fonc.2017.00053 · 2017 · External reference

Indicators of multifocality in papillary thyroid carcinoma concurrent with Hashimoto’s thyroiditis

2019 · External reference

Multi-unifocality (Muf), in contrast to multifocality, in thyroid lesions: Relation to lymphocytic thyroiditis

10.1111/pin.13421 · 2024 · External reference

Autoimmune thyroiditis and risk of Malignancy in children with thyroid nodules

10.1089/thy.2022.0241 · 2022 · External reference

Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: A single-center prospective study

10.1089/thy.2009.0450 · 2010 · External reference

Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes

10.1001/jamanetworkopen.2021.18526 · 2021 · External reference

Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer

10.1530/erc-17-0085 · 2017 · External reference

The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: A meta-analysis

10.1530/eje-12-0903 · 2013 · External reference

Associations between Hashimoto thyroiditis and clinical outcomes of papillary thyroid cancer: A meta-analysis of observational studies

10.3803/enm.2018.33.4.473 · 2018 · External reference

Correlation analysis of Hashimoto's thyroiditis with papillary thyroid carcinoma occurrence and its central lymph node metastasis: A single center experience

10.3389/fendo.2024.1420998 · 2024 · External reference

Prevalence and impact of Braf mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis: A systematic review with meta-analysis

10.3389/fendo.2023.1273498 · 2023 · External reference

Hashimoto's thyroiditis and papillary thyroid carcinoma: A follow-up study in patients with absence of aggressive risk factors at the surgery of the primary tumor

10.3390/diagnostics13193068 · 2023 · External reference

A prospective multicenter study examining the relationship between thyroid cancer treatment outcomes and the presence of autoimmune thyroiditis

10.1089/thy.2023.0052 · 2023 · External reference

The evaluation of locoregional tumoral involvement in the cooccurrence of Hashimoto thyroiditis with papillary thyroid cancer: A case controlled study

10.1186/s12902-023-01322-5 · 2023 · External reference

Mutation of Hashimoto's thyroiditis and papillary thyroid carcinoma related genes and the screening of candidate genes

10.3389/fonc.2021.813802 · 2021 · External reference

Identification and functional characterization of hub genes Clta, Edil3, Hapln1, and Hip1 as diagnostic biomarkers and therapeutic targets in thyroid cancer and Hashimoto's thyroiditis

10.1007/s10238-025-01689-w · 2025 · External reference

Papillary thyroid cancer: Genetic alterations and molecular biomarker investigations

10.7150/ijms.29935 · 2019 · External reference

The occurrence of gene fusions in thyroid lesions and the relation with chronic lymphocytic thyroiditis

10.1111/pin.70081 · 2026 · External reference

Expression of the Ret/Ptc fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis

10.1097/00005537-199701000-00019 · 1997 · External reference

Correlation between the clinicopathological features of papillary thyroid carcinoma complicated with Hashimoto's thyroiditis, Braf V600e gene mutation, and Ret gene rearrangement

10.29271/jcpsp.2024.04.445 · 2024 · External reference

Coexisting Ret/Ptc and Tert promoter mutation predict poor prognosis but effective Ret and Mek targeting in thyroid cancer

10.1210/clinem/dgae327 · 2024 · External reference

Ret/Ptc-1 activation in Hashimoto thyroiditis

10.1177/106689690000800305 · 2000 · External reference

Induction of a proinflammatory program in normal human thyrocytes by the Ret/Ptc1 oncogene

10.1073/pnas.0503039102 · 2005 · External reference

Clinicopathological features of Ccdc6-Ret and Ncoa4-Ret fusions in thyroid cancer: A single-center retrospective cohort study in a Chinese population

10.1089/thy.2024.0151 · 2024 · External reference

Identification of oncogenic alterations in 124 cases of pediatric papillary thyroid carcinoma: Bend7::Alk, Dlg5::Ret, and Ccdc30::Ros1 fusions induce Mapk pathway activation

10.1007/s12022-025-09850-7 · 2025 · External reference

Braf V600e mutation and its association with clinicopathological features of papillary thyroid cancer: A meta-analysis

10.1210/jc.2012-2104 · 2012 · External reference

Effect and interactions of Braf on lymph node metastasis in papillary thyroid carcinoma with Hashimoto thyroiditis

10.1210/clinem/dgad667 · 2024 · External reference

The dual oncogenic and protective roles of Hashimoto’s thyroiditis in papillary thyroid carcinoma: A cohort-based meta-analysis

10.1186/s12957-025-04184-4 · 2026 · External reference

Chronic lymphocytic thyroiditis and Braf V600e in papillary thyroid carcinoma

10.1530/erc-15-0408 · 2016 · External reference

Braf mutation positive papillary thyroid carcinoma is less advanced when Hashimoto’s thyroiditis lymphocytic infiltration is present

10.1111/cen.12194 · 2013 · External reference

Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods

10.3389/fendo.2023.1140094 · 2023 · External reference

Identification of Serpina1 promoting better prognosis in papillary thyroid carcinoma along with Hashimoto's thyroiditis through Wgcna analysis

10.3389/fendo.2023.1131078 · 2023 · External reference

Bioinformatic analysis of Serpina1 expression in papillary thyroid carcinoma and its potential association with Hashimoto's thyroiditis

10.1007/s12672-025-02079-0 · 2025 · External reference

Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer

10.7150/ijms.63402 · 2021 · External reference

Significance of Dmbt1 in papillary thyroid carcinoma concurrent with Hashimoto's thyroiditis

10.3389/fonc.2021.680873 · 2021 · External reference

Effects of trace elements on endocrine function and pathogenesis of thyroid diseases-a literature review

10.3390/nu17030398 · 2025 · External reference

Autoimmune thyroid disorders

10.1155/2013/509764 · 2013 · External reference

Iodoprophylaxis and thyroid autoimmunity: An update

10.1007/s12026-021-09192-6 · 2021 · External reference

The changing incidence of thyroid carcinoma in Shenyang, China before and after universal salt iodization

10.12659/msm.883736 · 2013 · External reference

Iodine intake as a risk factor for thyroid cancer: A comprehensive review of animal and human studies

10.1186/s13044-015-0020-8 · 2015 · External reference

The relationship between iodine intake and the risk of thyroid cancer: A meta-analysis

10.1097/md.0000000000006734 · 2017 · External reference

Iodine promotes thyroid cancer development via Spanxa1 through the Pi3k/Akt signalling pathway

10.3892/ol.2019.10391 · 2019 · External reference

Increased incidence of Hashimoto thyroiditis in selenium deficiency: A prospective 6-year cohort study

10.1210/clinem/dgac410 · 2022 · External reference

Selenium and thyroid diseases

10.3389/fendo.2023.1133000 · 2023 · External reference

Decreased thyroid peroxidase antibody titer in response to selenium supplementation in autoimmune thyroiditis and the influence of a selenoprotein P gene polymorphism: A prospective, multicenter study in China

10.1089/thy.2017.0230 · 2018 · External reference

Effect of selenium on thyroid autoimmunity and regulatory T cells in patients with Hashimoto's thyroiditis: A prospective randomized-controlled trial

10.1111/cts.12993 · 2021 · External reference

A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer

10.1089/thy.2012.0548 · 2013 · External reference

Associations of metal profiles in blood with thyroiditis: A cross-sectional study

10.1007/s11356-022-23625-1 · 2023 · External reference

Sex-specific associations of five serum essential metal elements with thyroid nodules in euthyroid adults: A cross-sectional study

10.1007/s12011-023-04024-0 · 2024 · External reference

The role of selected trace elements in oxidoreductive homeostasis in patients with thyroid diseases

10.3390/ijms24054840 · 2023 · External reference

Epstein-Barr virus in thyroid disease: An integrated immunovirological perspective

10.3389/fimmu.2025.1687214 · 2025 · External reference

Thyroid autoimmune diseases and thyroid tumors: Would Ebv infection be the link

10.1002/jcp.28641 · 2019 · External reference

Demonstration of Epstein-Barr virus by in situ hybridization in papillary thyroid carcinomas developing on background of Hashimoto's thyroiditis

10.1055/a-2322-7355 · 2024 · External reference

Epstein-Barr virus (Ebv) and autoimmune diseases: Pathogenic mechanisms and therapeutic insights

10.1002/jmv.70785 · 2026 · External reference

Macrophage involvement in Epstein-Barr virus-related tumors

10.3892/etm_00000044 · 2010 · External reference

Thyroid involvement in hepatitis C virus-infected patients with/without mixed cryoglobulinemia

10.3389/fendo.2017.00159 · 2017 · External reference

Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection

10.1155/2014/935131 · 2014 · External reference

Hepatitis C virus E2 protein induces upregulation of Il-8 pathways and production of heat shock proteins in human thyroid cells

10.1210/jc.2016-3403 · 2017 · External reference

Viral infection and thyroid disorders: A narrative review

10.3389/fmicb.2025.1625179 · 2025 · External reference

Oncodb: An interactive online database for analysis of gene expression and viral infection in cancer

10.1093/nar/gkab970 · 2021 · External reference

Smoke and autoimmunity: The fire behind the disease

10.1016/j.autrev.2016.01.001 · 2016 · External reference

Effect of cigarette smoking on thyroid cancer: Meta-analysis

10.3803/enm.2021.954 · 2021 · External reference

Immune and inflammatory cells in thyroid cancer microenvironment

10.3390/ijms20184413 · 2019 · External reference

The role of the immune system in the course of Hashimoto's thyroiditis: The current state of knowledge

10.3390/ijms25136883 · 2024 · External reference

Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis

10.1007/s00262-015-1705-5 · 2015 · External reference

Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma

10.1089/thy.2006.0306 · 2007 · External reference

Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma

10.1111/j.1365-2265.2012.04482.x · 2012 · External reference

Chemokine (C-X-C motif) ligand (Cxcl)10 in autoimmune diseases

10.1016/j.autrev.2013.10.010 · 2014 · External reference

Chemokines in thyroid autoimmunity

10.1016/j.beem.2023.101773 · 2023 · External reference

Cxcr3 in carcinoma progression

10.14670/hh-11-594 · 2015 · External reference

Differential expression profile of Cxcr3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis

10.18632/oncotarget.23502 · 2017 · External reference

The distinct roles of Cxcr3 variants and their ligands in the tumor microenvironment

10.3390/cells8060613 · 2019 · External reference

Interferon-G and tumor necrosis factor-a sustain secretion of specific Cxc chemokines in human thyrocytes: A first step toward a differentiation between autoimmune and tumor-related inflammation

10.1210/jc.2012-2555 · 2013 · External reference

Mechanisms of the impact of Hashimoto thyroiditis on papillary thyroid carcinoma progression: Relationship with the tumor immune microenvironment

10.3803/enm.2020.35.2.443 · 2020 · External reference

Do helper T cell subtypes in lymphocytic thyroiditis play a role in the antitumor effect

10.4132/jptm.2016.07.25 · 2016 · External reference

The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential Pd-1/Pd-L1 expression

10.3389/fendo.2022.959477 · 2022 · External reference

The possible role of Cd4+Cd25highfoxp3+/Cd4+Il-17a+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis

10.1007/s12020-015-0569-y · 2015 · External reference

Expression levels of interleukin-17 and interferon-Γ in peripheral blood and relationship with thyroid function in patients with Hashimoto's thyroiditis

10.3389/fmolb.2025.1645736 · 2025 · External reference

Il-17 a correlates with disease progression in papillary thyroid carcinoma

10.1186/s13000-023-01362-4 · 2023 · External reference

Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls

2016 · External reference

Il-17a increases Mhc class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis

10.1186/s13000-019-0832-2 · 2019 · External reference

Heterogeneity of tissue Il-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases

10.1097/md.0000000000011211 · 2018 · External reference

Anti-tumor immunity and autoimmunity: A balancing act of regulatory T cells

10.1007/s00262-003-0444-1 · 2004 · External reference

Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis

10.1007/s12094-014-1222-6 · 2015 · External reference

Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis

10.1177/0300060520919222 · 2020 · External reference

Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool

10.1186/s40463-014-0022-x · 2014 · External reference

Immunohistochemical expression of Tgf-B1, Smad4, Smad7, Tgfβrii and Cd68-positive Tam densities in papillary thyroid cancer

10.3889/oamjms.2018.110 · 2018 · External reference

Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: Deciphering immunological links

10.1016/j.heliyon.2019.e03077 · 2020 · External reference

Interactions of lymphocytes, thyrocytes and fibroblasts in Hashimoto's thyroiditis: An immunohistochemical and ultrastructural study

10.1159/000331857 · 2011 · External reference

Role of cytotoxic T cells and Pd-1 immune checkpoint pathway in papillary thyroid carcinoma

10.3389/fendo.2022.931647 · 2022 · External reference

Lymphocytic thyroiditis transcriptomic profiles support the role of checkpoint pathways and B cells in pathogenesis

10.1089/thy.2021.0694 · 2022 · External reference

Tertiary lymphoid structures in cancer: Spatiotemporal heterogeneity, immune orchestration, and translational opportunities​​

10.1186/s13045-025-01754-7 · 2025 · External reference

Papillary thyroid carcinoma landscape and its immunological link with Hashimoto thyroiditis at single-cell resolution

10.3389/fcell.2021.758339 · 2021 · External reference

Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma

10.1186/s13046-025-03341-7 · 2025 · External reference

Impact of Hashimoto's thyroiditis on the tumor microenvironment in papillary thyroid cancer: Insights from single-cell analysis

10.3389/fendo.2024.1339473 · 2024 · External reference

Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto's thyroiditis

10.1038/s41467-022-28120-2 · 2022 · External reference

Cancer-associated fibroblasts in papillary thyroid carcinoma

10.1007/s10238-023-00998-2 · 2023 · External reference

An integrated single-cell and spatial transcriptomic atlas of thyroid cancer progression identifies prognostic fibroblast subpopulations

10.1172/jci.insight.191990 · 2026 · External reference

Paracrine signaling in cancer-associated fibroblasts: Central regulators of the tumor immune microenvironment

10.1186/s12967-025-06744-4 · 2025 · External reference

Macrophage-mediated subversion of anti-tumour immunity

10.3390/cells8070747 · 2019 · External reference

The immune network in thyroid cancer

10.1080/2162402x.2016.1168556 · 2016 · External reference

Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype

10.1136/jitc-2019-000339 · 2020 · External reference

Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer

10.1096/fj.201700629r · 2018 · External reference

Dendritic cells and cancer immunity

10.1016/j.it.2016.09.006 · 2016 · External reference

Higher intratumoral expression of Cd1a, tryptase, and Cd68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: Correlation with clinical and pathological parameters

10.1089/thy.2011.0059 · 2011 · External reference

Myeloid-derived suppressor cells in the tumor microenvironment: Expect the unexpected

10.1172/jci80005 · 2015 · External reference

Papillary thyroid carcinoma emerging from Hashimoto thyroiditis demonstrates increased Pd-L1 expression, which persists with metastasis

10.1007/s12022-018-9540-9 · 2018 · External reference

Chronic lymphocytic thyroiditis with oncocytic metaplasia influences Pd-L1 expression in papillary thyroid carcinoma

10.1007/s12105-024-01618-5 · 2024 · External reference

Dual faces of Ifnγ in cancer progression: A role of Pd-L1 induction in the determination of pro- and antitumor immunity

10.1158/1078-0432.ccr-16-0224 · 2016 · External reference

Analysis of the Pd-1/Pd-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity

10.1016/j.jaut.2019.05.013 · 2019 · External reference

From biomarkers to therapeutic targets: The promise of Pd-L1 in thyroid autoimmunity and cancer

10.7150/thno.50333 · 2021 · External reference

The role of the transcription factor nuclear factor-kappa B in thyroid autoimmunity and cancer

10.3389/fendo.2018.00471 · 2018 · External reference

Tumor inflammatory microenvironment of the thyroid cancer: Relationship between regulatory T-cell imbalance, and P-Nfkb (P65) expression-a preliminary study

10.3390/jcm12216817 · 2023 · External reference

Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the Pi3k/Akt pathway

10.1016/j.jamcollsurg.2006.12.037 · 2007 · External reference

Hashimoto's thyroiditis pathology and risk for thyroid cancer

10.1089/thy.2013.0588 · 2014 · External reference

Thyroid autoimmunity and thyroid cancer: Review focused on cytological studies

10.1159/000468928 · 2017 · External reference

Thyrotropin and thyroid cancer diagnosis: A systematic review and dose-response meta-analysis

10.1210/jc.2012-1083 · 2012 · External reference

Tsh-activated signaling pathways in thyroid tumorigenesis

10.1016/j.mce.2003.10.029 · 2003 · External reference

Tsh overcomes Braf(V600e)-induced senescence to promote tumor progression via downregulation of P53 expression in papillary thyroid cancer

10.1038/onc.2015.253 · 2016 · External reference

Thyroid stimulating hormone levels and Brafv600e mutation contribute to pathophysiology of papillary thyroid carcinoma: Relation to outcomes

10.1016/j.pathophys.2019.05.001 · 2019 · External reference

Association of thyroid autoantibodies with aggressive characteristics of papillary thyroid cancer: A case-control study

10.1186/s12957-024-03501-7 · 2024 · External reference

High Tpoab levels (>1300 Iu/Ml) indicate multifocal Ptc in Hashimoto's thyroiditis patients and support total thyroidectomy

10.1177/0194599815581831 · 2015 · External reference

Preoperative thyroid peroxidase antibody predicts recurrence in papillary thyroid carcinoma: A consecutive study with 5,770 cases

10.3389/fonc.2022.881024 · 2022 · External reference

The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma

10.1002/ijc.31944 · 2019 · External reference

Prognostic value of change in antithyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma

10.1007/s12094-017-1782-3 · 2018 · External reference

Investigating antithyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: A meta-analysis and systematic review

10.1089/thy.2019.0368 · 2020 · External reference

Thyroid antibody status is associated with central lymph node metastases in papillary thyroid carcinoma patients with Hashimoto's thyroiditis

10.1245/s10434-019-07256-4 · 2019 · External reference

Association of thyroglobulin antibody and thyroid peroxidase antibody status with aggressive features in papillary thyroid carcinoma with Ha Shimoto’s thyroiditis

10.21037/gs-2025-47 · 2025 · External reference

The Mir-200 family of micrornas: Fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers

10.3390/cancers13235874 · 2021 · External reference

Adar1-mediated Rna editing is a novel oncogenic process in thyroid cancer and regulates Mir-200 activity

10.1038/s41388-020-1248-x · 2020 · External reference

Competitive endogenous Rna is an intrinsic component of Emt regulatory circuits and modulates Emt

10.1038/s41467-019-09649-1 · 2019 · External reference

Identification of long noncoding Rnas associated with the clinicopathological features of papillary thyroid carcinoma complicated with Hashimoto's thyroiditis

10.3389/fonc.2022.766016 · 2022 · External reference

Interaction of Bancr in the relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma expression patterns and possible molecular mechanisms

10.1002/jgm.3663 · 2024 · External reference

Identification of long noncoding Rnas deregulated in papillary thyroid cancer and correlated with Brafv600e mutation by bioinformatics integrative analysis

10.1038/s41598-017-01957-0 · 2017 · External reference

Comprehensive analysis of Lncrna-mediated Cerna regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis

10.1186/s12902-022-01173-6 · 2022 · External reference

Emerging roles for noncoding Rnas in autoimmune thyroid disease

10.1210/endocr/bqaa053 · 2020 · External reference

Gut microbiota reshapes the Tnbc immune microenvironment: Emerging imm unotherapeutic strategies

10.1016/j.phrs.2025.107726 · 2025 · External reference

Causal relationship between gut microbiota and thyroid nodules: A bidirectional two-sample Mendelian randomization study

10.3389/fendo.2024.1417009 · 2024 · External reference

Causal relationship of genetically predicted gut microbiota with thyroid cancer: A bidirectional two-sample Mendelian randomization study

10.3389/fendo.2024.1284472 · 2024 · External reference

Detection of alterations in the gut microbiota and intestinal permeability in patients with Hashimoto thyroiditis

10.3389/fimmu.2021.579140 · 2021 · External reference

Integrative analysis of gut microbiome and host transcriptome reveal novel molecular signatures in Hashimoto's thyroiditis

10.1186/s12967-024-05876-3 · 2024 · External reference

Unveiling the role of gut microbiota and metabolites in autoimmune thyroid diseases: Emerging perspectives

10.3390/ijms252010918 · 2024 · External reference

The relationship between thyroid and human-associated microbiota: A systematic review of reviews

10.1007/s11154-023-09839-9 · 2024 · External reference

Correlation between the intestinal microflora and peripheral blood Th1/Th2 balance in hypothyroidism during the first half of pregnancy

10.3389/fcimb.2023.1159238 · 2023 · External reference

Effects of iodine intake on gut microbiota and gut metabolites in Hashimoto thyroiditis-diseased humans and mice

10.1038/s42003-024-05813-6 · 2024 · External reference

Modulation of intestinal flora: A novel immunotherapeutic approach for enhancing thyroid cancer treatment

10.1007/s12602-025-10471-z · 2025 · External reference

The intricate interplay of noncoding RNAs and the gut microbiome in gastrointestinal and endocrine-related cancers

10.1007/978-3-032-08530-6_2 · 2026 · External reference

Cytokine secretion and pyroptosis of thyroid follicular cells mediated by enhanced NLRP3, NLRP1, NLRC4, and AIM2 inflammasomes are associated with autoimmune thyroiditis

10.3389/fimmu.2018.01197 · 2018 · External reference

Multi-regulatory potency of USP1 on inflammasome components promotes pyroptosis in thyroid follicular cells and contributes to the progression of Hashimoto's thyroiditis

10.1186/s10020-024-00885-w · 2024 · External reference

Targeting inflammasomes as an immunotherapeutic strategy for cancer

10.1186/s12967-025-06665-2 · 2025 · External reference

Intercellular adhesion molecule 1 is a sensitive and diagnostically useful immunohistochemical marker of papillary thyroid cancer (PTC) and of PTC-like nuclear alterations in Hashimoto's thyroiditis

10.3892/ol.2016.4104 · 2016 · External reference

Papillary thyroid cancer with Hashimoto's thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-B expression

10.1007/s10238-022-00857-6 · 2023 · External reference

N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways

10.18632/oncotarget.14101 · 2017 · External reference

Genetic alterations in papillary thyroid carcinoma with Hashimoto's thyroiditis: ANK3, an indolent maintainer of papillary thyroid carcinoma

10.3389/fonc.2022.894786 · 2022 · External reference

Genetic relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto's thyroiditis

10.1371/journal.pone.0234566 · 2020 · External reference

Role of papillary thyroid carcinoma patients with Hashimoto thyroiditis: Evaluation of oxidative stress and inflammatory markers

10.1007/s12094-022-02891-y · 2022 · External reference

Oxidative stress links thyroid autoimmunity to cancer: Peroxiredoxin 2 protection via genomic and single-cell insights

10.1177/10849785251360744 · 2025 · External reference

Microchimerism and endocrine disorders

10.1210/jc.2011-3160 · 2012 · External reference

Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: A retrospective analysis of 635 patients

10.1186/s12902-022-00945-4 · 2022 · External reference

Effects of chronic lymphocytic thyroiditis on the clinicopathological features of papillary thyroid cancer

10.1159/000486367 · 2018 · External reference

The impact of Hashimoto's thyroiditis on the clinical outcome of papillary thyroid cancer after radioactive iodine therapy: A propensity score matching study

10.1007/s12020-024-03973-3 · 2024 · External reference

Hashimoto thyroiditis and progression of papillary thyroid cancer: 10-year retrospective cohort study

10.2196/80535 · 2026 · External reference

Clinical relationship between IgG4-positive Hashimoto's thyroiditis and papillary thyroid carcinoma

10.1210/jc.2015-3783 · 2016 · External reference

Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis

10.1007/s12022-010-9124-9 · 2010 · External reference

Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer

10.3389/fendo.2022.987906 · 2022 · External reference

Correlation of TGAb with clinicopathological features and unfavorable efficacy of 131I ablation in PTC

10.1210/clinem/dgae898 · 2025 · External reference

Multimodal ultrasound and artificial intelligence for characterization of thyroid nodules in Hashimoto's thyroiditis: Current challenges and future perspectives

10.1186/s40001-026-04092-7 · 2026 · External reference

A multicenter diagnostic study of thyroid nodule with Hashimoto's thyroiditis enabled by Hashimoto's thyroiditis nodule-artificial intelligence model

10.1007/s00330-025-11422-6 · 2025 · External reference